For the quarter ending 2025-09-30, AFJK made $482,171 in revenue. $352,019 in net income. Net profit margin of 73.01%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | |
|---|---|---|---|---|
| Formation and operating costs | 130,152 | 41,604 | 266,196.5 | |
| Loss from operations | -130,152 | -41,604 | -266,196.5 | |
| Interest earned on cash held in trust | 482,171 | 466,574 | 904,250.25 | |
| Total other income | 482,171 | 466,574 | 904,250.25 | |
| Net income | 352,019 | 424,970 | 638,053.75 | |
| Basic net income per share, ordinary shares | 0.06 | - | - | |
| Basic weighted average shares outstanding, ordinary shares | 3,995,733 | - | - | |
| Diluted net income per share, ordinary shares | 0.06 | - | - | |
| Diluted weighted average shares outstanding, ordinary shares | 3,995,733 | - | - | |
Aimei Health Technology Co., Ltd. (AFJK)
Aimei Health Technology Co., Ltd. (AFJK)